Parents and Healthcare Workers Have Different Preferences for End-of-Life Care for Children With Cancer
Parents prefer palliative chemotherapy for their child with cancer who is not expected to survive, while healthcare workers favor supportive care.
Chemoradiotherapy Shows Promise in Nonmelanoma Skin Cancer of the Head and Neck
Chemotherapy given at the same time as radiotherapy may be a feasible treatment for high-risk nonmelanoma skin cancer (NMSC) of the head and neck.
Hair Professionals Often Check Customers for Worrisome Skin Lesions
Some cosmetologists and barbers inspect their customers' scalps, necks, and faces for the presence of skin lesions that they think may be cancerous.
Better Communication of Complex Medical Information Needed
Researchers are urging oncologists to improve the communication of complex medical information to their patients.
Men Undergoing Prostate Biopsy Have Higher Hospitalization Rates
The rate of hospitalization in older men within 30 days of a prostate biopsy is more than double that occurring in a control population not undergoing a biopsy.
Hospitals for Vulnerable Patients Less Likely to Provide Optimal Lung Cancer Care
New data show that patients treated for lung cancer at high safety-net burden hospitals undergo curative-intent surgery significantly less often than individuals treated at low safety-net burden facilities.
Update on Bone Disease in Multiple Myeloma
Bone disease occurs in about 84% of patients with multiple myeloma and is responsible for a great deal of morbidity, including pain, hypercalcemia, compromised quality of life, and pathological fracture.
Ibandronate and Radiotherapy Provide Equivalent Pain Relief in Metastatic Prostate Cancer That Has Metastasized to the Bone
A single dose of radiotherapy and a single injection of ibandronate provided similar pain relief from bone metastases in men with metastatic prostate cancer.
Castration-Resistant Prostate Cancer: A Conversation With Cora N. Sternberg, MD
Physicians and patients with castration-resistant prostate cancer (CRPC) have an increasing number of treatment options that improve outcomes.
Adjuvant Zoledronic Acid May Improve Disease-Free Survival for Postmenopausal Women With Breast Cancer
A subanalysis of the AZURE study found that postmenopausal women had a disease-free survival advantage from the addition of zoledronic acid to their therapy.
Maintenance Therapy With Bevacizumab/Pemetrexed Appears Superior to Bevacizumab Alone
Maintenance therapy with bevacizumab plus pemetrexed achieved a 4-month benefit in progression-free survival (PFS) versus bevacizumab maintenance therapy alone.
Personalized Medicine Offers Great Hope, Great Challenges
Cancer treatment is moving from a one-size-fits-all approach to personalized medicine, which means matching the right drug with the right tumor characteristics.
Early Alopecia May Be Linked to Prostate Cancer
New data support a potential link between early-onset androgenic alopecia and the development of prostate cancer.
Prostate Cancer Test Deemed Unnecessary by Government Panel
After decades of use, a routine test used for diagnosing prostate cancer has come under fire after a government panel questioned its safety.
University of Pennsylvania's Abramson Cancer Center: Leaders in Groundbreaking Therapies
Established in 1973 as the University of Pennsylvania's Cancer Center and subsequently renamed in 2002, the Abramson Cancer Center is a world leader in research, patient care, and education.
November 2011: Trials in Progress
This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Oncology Meeting.
Not All Viruses Are the Same
A look at tweaking the corruptive influence of the virus information code to selectively corrupt cancer cells while sparing (normal) cells that do not have a specific cancer phenotype.
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.